期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 374, 期 12, 页码 1167-1176出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp1502240
关键词
-
资金
- Abiomed
- AstraZeneca
- Boehringer Ingelheim
- Daiichi Sankyo
- Eli Lilly
- Janssen
- Stealth Peptides
- Medicines Company
- Angel Medical Systems
- Biotie Therapies
- Faculty Connection
- Merck
- Medscape
- Gilead Sciences
A 73-year-old farmer with a 15-month history of stable angina presents for consultation. He has curtailed his farming activity to avoid chest discomfort, for which he uses nitroglycerin (0.4 mg sublingually) approximately 3 times per month. His heart rate is 59 beats per minute, and his blood pressure is 132/72 mm Hg. He had unstable angina 12 years earlier, and a drug-eluting stent was implanted in his left anterior descending artery; no other obstructive coronary artery disease was noted at that time. His medications include aspirin, lisinopril (20 mg daily) for hypertension, and atorvastatin (40 mg daily). How should this case be evaluated and managed?
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据